Boston Scientific acquiring Penumbra in $14.5bn deal
Boston Scientific Corporation has entered into a definitive agreement to acquire Penumbra in a transaction valued at approximately $14.5bn. The American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices announced it was buying California-based medical device company Penumbra on January 15. For operators and investors, the deal represents a significant pivot for Boston Scientific as it seeks…